Fusion Pharmaceuticals
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Fusion Pharmaceuticals's balance sheet done over the years? Its assets were worth $285,836,000 last year, which is more than in the previous period. 22% of Fusion Pharmaceuticalsโ€™s total assets is currently financed by debt. Its liabilities reached the amount of $63,356,000, which means an increase by 11% compared compared to last year.

Debt to Assets

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN): Debt to assets
2018 31391000 49.30M 157.08%
2019 69400000 102.88M 148.25%
2020 310676000 16.16M 5.2%
2021 252271000 20.81M 8.25%
2022 219064000 56.84M 25.95%
2023 285836000 63.35M 22.17%

FUSN Balance Sheet (2018 โ€“ 2023)

2023 2022 2021 2020 2019 2018
Assets
Current assets:
Cash and cash equivalents
61.92M43.86M52.89M90.51M65.34M28.76M
Short term investments
172.15M127.01M147.89M131.88M00
Net receivables
4.21M1.72M357K794K428K483K
Inventory
0-9.86M10.37M4.24M503K835K
Other current assets
5.10M509K233K727K278K150K
Total current assets
243.39M178.99M211.76M228.16M66.55M30.23M
Non-current assets:
Property, Plant and Equipment
23.89M10.31M9.45M1.96M1.27M1.10M
Goodwill
000000
Intangible assets
000000
Long term investments
14.58M15.76M19.98M77.08M1.49M0
Other non-current assets
849K9.18M9.42M2.81M1.49M32K
Total non-current assets
42.44M40.06M40.50M82.51M2.84M1.15M
Total assets
285.83M219.06M252.27M310.67M69.4M31.39M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
333K924K1.53M1M00
Short term debt
4.16M1.44M1.21M000
Total current liabilities
16.21M15.06M12.51M11.85M4.27M1.59M
Non-current liabilities:
Long term debt
34.77M38.81M5.50M05.74M0
Deferred tax
000000
Other non-current liabilities
301K299K297K306K92.87M47.70M
Total non-current liabilities
47.13M41.77M8.30M4.30M98.61M47.70M
Total liabilities
63.35M56.84M20.81M16.16M102.88M49.30M
Data sourceData sourceData sourceData source